Organoids represent a major breakthrough in stem cell research, offering three-dimensional (3D), self-organizing structures that mimic the architecture and functionality of human organs. These miniaturized, tissue-like models, derived from induced pluripotent stem cells (iPSCs), provide an unprecedented opportunity to study human development, disease mechanisms, and drug responses in a physiologically relevant environment.
At the Coriell Institute, we specialize in developing, characterizing, and optimizing iPSC-derived organoids, enabling researchers to push the boundaries of biomedical science. Our expertise ensures that organoids retain high fidelity toin vivotissues, offering scalable, reproducible, and genetically stable models for diverse applications.
Types of iPSC-Derived Organoids
Coriell is actively developing and optimizing multiple organoid models, including:
- Brain Organoids: Mimic cerebral architecture, supporting research into neurodevelopmental and neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and autism spectrum disorders.
- Cardiac Organoids: Recapitulate heart structure and function, making them ideal for cardiovascular disease modeling and drug testing.
- Intestinal Organoids: Serve as models for gastrointestinal diseases, studying conditions like inflammatory bowel disease (IBD) and colorectal cancer.
- Liver Organoids: Enable investigations into liver disease, drug metabolism, and toxicity studies.
- Kidney Organoids: Replicate key aspects of renal development, allowing studies on kidney disease and nephrotoxicity.
- Lung Organoids: Provide platforms for researching respiratory diseases, viral infections, and the effects of airborne toxins.
Applications of iPSC-Derived Organoids
Coriell’s iPSC-derived organoids are powerful tools for:
- Disease Modeling: Organoids accurately replicate patient-specific disease conditions, providing insight into neurodegenerative, cardiac, gastrointestinal, and genetic disorders.
- Drug Discovery & Toxicology Studies: Pharmaceutical companies and researchers use organoid models to test drug efficacy and toxicity before advancing to clinical trials.
- Personalized Medicine: Patient-derived organoids enable precision drug testing, allowing for individualized treatment approaches.
- Tissue Engineering & Regenerative Medicine: Organoids serve as platforms for studying tissue repair, transplantation, and regenerative therapies.
- Host-Microbe Interactions: Gut and lung organoids help researchers explore microbiome interactions, infections, and immune responses in a controlled setting.
Tell us about your needs
